National nonprofit makes this and other investments in higher education to bolster access to veterinary care PHOENIX, May 25, 2023 /PRNewswire/ — PetSmart Charities® will name an endowed chair at the University of California, Davis, School of Veterinary Medicine for $6 million. The landmark partnership marks the largest gift to date made by the top … Read more
SAN FRANCISCO, May 25, 2023 /PRNewswire/ — The global nanomedicine market size is expected to reach USD 410.15 billion by 2030, expanding at 11.57% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The advantages of nanomedicine in numerous healthcare applications, the emergence of novel drug delivery technologies, and … Read more
SAN DIEGO, May 24, 2023 /PRNewswire/ — Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial-stage oncology company, today announced that the SAPPHIRE study did not meet its primary endpoint of overall survival at the final analysis. SAPPHIRE is a Phase 3 study evaluating sitravatinib in combination with nivolumab (OPDIVO®)1 versus docetaxel in patients with second or third … Read more
Combining tissue profiling with whole transcriptome spatial analysis and high-plex protein co-detection enables a deeper, more holistic understanding of tissue organization PLEASANTON, Calif., May 24, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of a new Visium CytAssist Gene and Protein Expression … Read more
ALAMEDA, Calif., May 24, 2023 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at William Blair’s 43rd Annual Growth Stock Conference on Wednesday, June 7, 2023. Event: William Blair’s 43rd Annual Growth Stock Conference Date: Wednesday, June 7, 2023 Time: 9:20am CT/ 7:20am PT A webcast … Read more
LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ — BIOLASE, Inc. (NASDAQ: BIOL) (“BIOLASE” or the “Company”), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the “Units”), with each Unit consisting of one share of BIOLASE’s Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with … Read more
– Preclinical and early research gene therapy programs discontinued –– Expected reductions of approximately 15% in residual 2023 OPEX – SOUTH PLAINFIELD, N.J., May 23, 2023 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the discontinuation of preclinical and early research programs in gene therapy as part of a strategic portfolio prioritization. PTC will continue … Read more
PLYMOUTH MEETING, Pa., May 23, 2023 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that the European Commission (EC) has granted orphan drug designation for INO-3107, the company’s product candidate for the treatment of Recurrent Respiratory … Read more
– Conference call and webcast to be held at 5:00 pm EDT – SOUTH PLAINFIELD, N.J., May 23, 2023 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today reported topline results from the MOVE-FA trial of vatiquinone in patients with Friedreich ataxia. The study did not meet its primary endpoint of statistically significant change in mFARS score … Read more
CHICAGO, May 23, 2023 /PRNewswire/ — GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company (the “Company”), today announced that its Board of Directors (the “Board”) established a special committee of the Board (the “Special Committee”) to consider a proposal (the “Proposal”) from its two largest stockholders to acquire all … Read more